Literature DB >> 33148663

Radiomic Detection of EGFR Mutations in NSCLC.

Giovanni Rossi1,2, Emanuele Barabino3, Alessandro Fedeli4, Gianluca Ficarra5, Simona Coco1, Alessandro Russo6, Vincenzo Adamo6, Francesco Buemi6, Lodovica Zullo1, Mariella Dono7, Giuseppa De Luca7, Luca Longo1, Maria Giovanna Dal Bello1, Marco Tagliamento1, Angela Alama1, Giuseppe Cittadini3, Paolo Pronzato1, Carlo Genova8,9.   

Abstract

Radiomics is defined as the use of automated or semi-automated post-processing and analysis of multiple features derived from imaging exams. Extracted features might generate models able to predict the molecular profile of solid tumors. The aim of this study was to develop a predictive algorithm to define the mutational status of EGFR in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC). CT scans from 109 treatment-naïve patients with NSCLC (21 EGFR-mutant and 88 EGFR-wild type) underwent radiomics analysis to develop a machine learning model able to recognize EGFR-mutant from EGFR-WT patients via CT scans. A "test-retest" approach was used to identify stable radiomics features. The accuracy of the model was tested on an external validation set from another institution and on a dataset from the Cancer Imaging Archive (TCIA). The machine learning model that considered both radiomic and clinical features (gender and smoking status) reached a diagnostic accuracy of 88.1% in our dataset with an AUC at the ROC curve of 0.85, whereas the accuracy values in the datasets from TCIA and the external institution were 76.6% and 83.3%, respectively. Furthermore, 17 distinct radiomics features detected at baseline CT scan were associated with subsequent development of T790M during treatment with an EGFR inhibitor. In conclusion, our machine learning model was able to identify EGFR-mutant patients in multiple validation sets with globally good accuracy, especially after data optimization. More comprehensive training sets might result in further improvement of radiomics-based algorithms. SIGNIFICANCE: These findings demonstrate that data normalization and "test-retest" methods might improve the performance of machine learning models on radiomics images and increase their reliability when used on external validation datasets. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 33148663     DOI: 10.1158/0008-5472.CAN-20-0999

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Development and validation of novel radiomics-based nomograms for the prediction of EGFR mutations and Ki-67 proliferation index in non-small cell lung cancer.

Authors:  Yinjun Dong; Zekun Jiang; Chaowei Li; Shuai Dong; Shengdong Zhang; Yunhong Lv; Fenghao Sun; Shuguang Liu
Journal:  Quant Imaging Med Surg       Date:  2022-05

2.  Prediction of TTF-1 expression in non-small-cell lung cancer using machine learning-based radiomics.

Authors:  Ruijie Zhang; Xiankai Huo; Qian Wang; Juntao Zhang; Shaofeng Duan; Quan Zhang; Shicai Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-23       Impact factor: 4.322

3.  CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy.

Authors:  Qian Lin; Hai Jun Wu; Qi Shi Song; Yu Kai Tang
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

4.  Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.

Authors:  Meilinuer Abdurixiti; Mayila Nijiati; Rongfang Shen; Qiu Ya; Naibijiang Abuduxiku; Mayidili Nijiati
Journal:  Br J Radiol       Date:  2021-05-12       Impact factor: 3.629

Review 5.  Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.

Authors:  Evelien A J van Genugten; Jetty A M Weijers; Sandra Heskamp; Manfred Kneilling; Michel M van den Heuvel; Berber Piet; Johan Bussink; Lizza E L Hendriks; Erik H J G Aarntzen
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

Review 6.  Artificial Intelligence Applications to Improve the Treatment of Locally Advanced Non-Small Cell Lung Cancers.

Authors:  Andrew Hope; Maikel Verduin; Thomas J Dilling; Ananya Choudhury; Rianne Fijten; Leonard Wee; Hugo Jwl Aerts; Issam El Naqa; Ross Mitchell; Marc Vooijs; Andre Dekker; Dirk de Ruysscher; Alberto Traverso
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

7.  Radiomic-based diagnostics in oncology: challenges toward clinical practice.

Authors:  Emanuele Barabino; Giovanni Rossi; Alessandro Fedeli; Giuseppe Cittadini; Carlo Genova
Journal:  Oncoscience       Date:  2021-06-02

Review 8.  Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade.

Authors:  Carlo Genova; Chiara Dellepiane; Paolo Carrega; Sara Sommariva; Guido Ferlazzo; Paolo Pronzato; Rosaria Gangemi; Gilberto Filaci; Simona Coco; Michela Croce
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

9.  Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics.

Authors:  Emanuele Barabino; Giovanni Rossi; Silvia Pamparino; Martina Fiannacca; Simone Caprioli; Alessandro Fedeli; Lodovica Zullo; Stefano Vagge; Giuseppe Cittadini; Carlo Genova
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

Review 10.  Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.

Authors:  Jing-Wen Ma; Meng Li
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.